NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Another simpler scenario would be the following. Just a hypothetical.

If Germany PFS and/or OS quickly showed statistical significance.

If NWBO stopped the controlled trial in Germany for efficacy, but allowed the U.S to continue enrolling 31 more patients with the the original manufacturing technique because they had their tumor lysate and dendritic cells.

What do you do?

A significant number of sites from Germany might very well demonstrate statistical efficacy comparatively early.

Well, there is new AA FDA guidance regarding significant number of sites, and another one on early demonstrations of efficacy.